top of page
HOME
ABOUT US
AURASE WOUND GEL
The Problem
Our Solution
Clinical Evidence
R&D Development Plan
NEWS
PUBLICATIONS
CONTACT
31/08/19, 11:00
Will chronic wounds have a better treatment? SolasCure, a new company in Hovione Capital’s portfolio.
Previous
Next
HOME
ABOUT US
AURASE WOUND GEL
The Problem
Our Solution
Clinical Evidence
R&D Development Plan
NEWS
PUBLICATIONS
CONTACT
bottom of page